Ads
related to: metastatic nsclc survival rates calculator- 2L mNSCLC Treatment
For Metastatic
NSCLC. Visit Physician Site.
- Efficacy & Safety Data
See If A 2L mNSCLC Treatment
Is An Option For Your Patients.
- Mechanism Of Action Info
See How A 2L Metastatic
NSCLC Therapy Works.
- mNSCLC Biomarker Info
Discover A Treatment For 2L mNSCLC
With This Actionable Biomarker
- Dosing & Administration
View Dosing & Preparation Info For
A 2L mNSCLC Treatment Option.
- Resources For Physicians
Downloadable Resources For Your
mNSCLC Patients & Their Caregivers.
- 2L mNSCLC Treatment
Search results
Results From The WOW.Com Content Network
Non-small-cell lung cancer (NSCLC), or non-small-cell lung carcinoma, is any type of epithelial lung cancer other than small-cell lung cancer (SCLC). NSCLC accounts for about 85% of all lung cancers. [1] [2] [3] As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small-cell carcinoma.
M describes distant metastasis (spread of cancer from one part of the body to another). The TNM staging system for all solid tumors was devised by Pierre Denoix of the Institut Gustave Roussy between 1943 and 1952, using the size and extension of the primary tumor, its lymphatic involvement, and the presence of metastases to classify the ...
In the United States there has been an increase in the 5-year relative survival rate between people diagnosed with cancer in 1975-1977 (48.9%) and people diagnosed with cancer in 2007-2013 (69.2%); these figures coincide with a 20% decrease in cancer mortality from 1950 to 2014. [8]
In medicine (oncology and other fields), performance status is an attempt to quantify cancer patients' general well-being and activities of daily life. This measure is used to determine whether they can receive chemotherapy, whether dose adjustment is necessary, and as a measure for the required intensity of palliative care.
Survival rate is a part of survival analysis.It is the proportion of people in a study or treatment group still alive at a given period of time after diagnosis. It is a method of describing prognosis in certain disease conditions, and can be used for the assessment of standards of therapy.
[23] [25] In the 5-FU clinical study cited above, people whose dose was adjusted to achieve a pre-determined target exposure realized an 84% improvement in treatment response rate and a six-month improvement in overall survival (OS) compared with those dosed by BSA. [23] 5-FU dose management avoids serious side effects experienced with BSA ...
Ads
related to: metastatic nsclc survival rates calculator